High-resolution imaging of the retina
High Resolution Retinal Imaging
This study is testing a new way to take detailed pictures of the retina to help doctors better understand and treat eye diseases like Stargardt's and age-related macular degeneration in people aged 7 and older.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 7 Years and up |
| Sex | All |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT01866371 on ClinicalTrials.gov |
What this trial studies
This study focuses on using adaptive optics scanning laser ophthalmoscopy (AOSLO) to capture high-resolution images of the retina in both healthy individuals and those with retinal diseases. By examining the morphology and function of the retina, the study aims to enhance the detection, diagnosis, and treatment of conditions such as Stargardt's disease, retinitis pigmentosa, and age-related macular degeneration. Participants aged 7 and older will undergo non-invasive retinal imaging, with a primary goal of identifying differences in retinal structure between affected and unaffected individuals. The study will involve case-control comparisons and will quantify changes in the cone photoreceptor mosaic and other retinal layers.
Who should consider this trial
Good fit: Ideal candidates include males and females aged 7 years or older with or without retinal diseases.
Not a fit: Patients at risk for acute glaucoma, those who are photophobic, or individuals with significant ocular opacities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic techniques and treatment strategies for various retinal diseases.
How similar studies have performed: Other studies utilizing high-resolution retinal imaging techniques have shown promise in advancing our understanding of retinal diseases, indicating that this approach is both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males or females age 7 years or older. * Parental/guardian permission (informed consent) and if appropriate, child assent. Child subjects age 7-17 must give assent. * Reasonable compliance with an imaging protocol as determined by the study personnel. Exclusion Criteria: * Individuals that are at risk to acute glaucoma. * Individuals that are photophobic and experience adverse psychological reactions to flashes of light. * Ocular opacities, high refractive error, and high frequency of nystagmus as determined by the study team.
Where this trial is running
Philadelphia, Pennsylvania
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Jessica IW Morgan, PhD — University of Pennsylvania
- Study coordinator: Jessica IW Morgan, PhD
- Email: jwmorgan@pennmedicine.upenn.edu
- Phone: 215-614-4196
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.